Leukocytoclastic vasculitis secondary to clozapine

Leukocytoclastic vasculitis (LCV) may be secondary to drugs, underlying infection, collagen vascular disorders, or malignancy. Drug-induced vasculitis contributes to 10% of vasculitic skin lesions cases usually developing within 7–21 days of treatment initiation. The present case highlights a report...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Shatavisa, Era, Nikhil, Mukherjee, Mala, Tripathi, Santanu Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341920/
https://www.ncbi.nlm.nih.gov/pubmed/30745661
http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_384_18
_version_ 1783389041099538432
author Mukherjee, Shatavisa
Era, Nikhil
Mukherjee, Mala
Tripathi, Santanu Kumar
author_facet Mukherjee, Shatavisa
Era, Nikhil
Mukherjee, Mala
Tripathi, Santanu Kumar
author_sort Mukherjee, Shatavisa
collection PubMed
description Leukocytoclastic vasculitis (LCV) may be secondary to drugs, underlying infection, collagen vascular disorders, or malignancy. Drug-induced vasculitis contributes to 10% of vasculitic skin lesions cases usually developing within 7–21 days of treatment initiation. The present case highlights a report of LCV in a 59-year-old male with a history of paranoid schizophrenia on clozapine therapy. The report upsurges the need to promote awareness and expedite diagnosis and treatment of drug-induced LCVs.
format Online
Article
Text
id pubmed-6341920
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-63419202019-02-11 Leukocytoclastic vasculitis secondary to clozapine Mukherjee, Shatavisa Era, Nikhil Mukherjee, Mala Tripathi, Santanu Kumar Indian J Psychiatry Case Report Leukocytoclastic vasculitis (LCV) may be secondary to drugs, underlying infection, collagen vascular disorders, or malignancy. Drug-induced vasculitis contributes to 10% of vasculitic skin lesions cases usually developing within 7–21 days of treatment initiation. The present case highlights a report of LCV in a 59-year-old male with a history of paranoid schizophrenia on clozapine therapy. The report upsurges the need to promote awareness and expedite diagnosis and treatment of drug-induced LCVs. Medknow Publications & Media Pvt Ltd 2019 /pmc/articles/PMC6341920/ /pubmed/30745661 http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_384_18 Text en Copyright: © 2019 Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Mukherjee, Shatavisa
Era, Nikhil
Mukherjee, Mala
Tripathi, Santanu Kumar
Leukocytoclastic vasculitis secondary to clozapine
title Leukocytoclastic vasculitis secondary to clozapine
title_full Leukocytoclastic vasculitis secondary to clozapine
title_fullStr Leukocytoclastic vasculitis secondary to clozapine
title_full_unstemmed Leukocytoclastic vasculitis secondary to clozapine
title_short Leukocytoclastic vasculitis secondary to clozapine
title_sort leukocytoclastic vasculitis secondary to clozapine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341920/
https://www.ncbi.nlm.nih.gov/pubmed/30745661
http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_384_18
work_keys_str_mv AT mukherjeeshatavisa leukocytoclasticvasculitissecondarytoclozapine
AT eranikhil leukocytoclasticvasculitissecondarytoclozapine
AT mukherjeemala leukocytoclasticvasculitissecondarytoclozapine
AT tripathisantanukumar leukocytoclasticvasculitissecondarytoclozapine

Ejemplares similares